5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines.
Studies were carried out on 5-aminolevulinic acid (ALA)-induced protoporphyrin (PpIX) synthesis in mice peritoneal macrophages and two human oral squamous cell carcinoma (OSCC) cell lines NT8e and 4451. Cells were treated with 200 microg/ml ALA for 15 h and PpIX accumulation was monitored by spectrofluorometry and phototoxicity to red light (630+/-20 nm) was measured by MTT assay. PpIX accumulation was higher in macrophages as compared to OSCC cells under both normal serum concentration (10%) and conditions of serum depletion. The results on phototoxicity measurements correlated well with the levels of PpIX accumulation in both macrophages and cancer cells. While red light caused 20% phototoxicity in macrophages, no phototoxicity was seen in 4451 cells at 10% serum. Decrease in serum concentration to 5% and 1% led to higher phototoxicity corresponding to 40% and 70% in macrophages and 10% and 15% in 4451 cells. Similar results were obtained in NT8e cell line. Propidium iodide staining followed by fluorescence microscopic observations on photodynamically treated co-culture of murine or human macrophages and cancer cells showed selective damage to macrophages. These results suggest that in OSCC, macrophages would contribute more to tumor PpIX level than tumor cells themselves and PDT may lead to selective killing of macrophages at the site of treatment. Since macrophages are responsible for production and secretion of various tumor growth mediators, the effect of selective macrophage killing on the outcome of PDT would be significant.
Sharma
Sulbha
S
Laser Biomedical Applications and Instrumentation Division, Raja Ramanna Center for Advanced Technology, R&D Block D, Indore 452 013, India.
Jajoo
Anjana
A
Dube
Alok
A
D000622:Aminolevulinic Acid / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001681:Biological Assay; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000648:ultrastructure; D045744:Cell Line, Tumor; D006801:Humans; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D008297:Male; D051379:Mice; D008856:Microscopy, Fluorescence; D009062:Mouth Neoplasms / Q000473:pathology / Q000648:ultrastructure; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000494:pharmacology* / Q000633:toxicity; D011419:Propidium / Q000737:chemistry; D011524:Protoporphyrins / Q000378:metabolism*
D017319:Photosensitizing Agents; D011524:Protoporphyrins; D011419:Propidium; D000622:Aminolevulinic Acid; C028025:protoporphyrin IX